Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-15

FDA Approved: LETROZOLE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for letrozole tablets submitted by Chartwell RX, LLC (a generic letrozole product).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)

Snippet

SUPPL AP for LETROZOLE (LETROZOLE)